GlassScriptPhysician profile
Nagaraj M Chetty
NPI 1508975293
$721.24
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $88.32 · 2021: $307 · 2022: $224.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $377.32 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $124.81 | 2021 | |
| Abbvie INC. | $75.32 | 2019-2021 | |
| Genzyme Corporation | $43.32 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $34.71 | 2022 | |
| Concordia Pharmaceuticals INC. | $22.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.73 | 2019 | |
| Allergan, INC. | $11.15 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.08 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nagaraj Chetty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.